Paclitaxel devices show no increased mortality compared to non-drug coated devices: SAFE-PAD study Dr. Kamal Kant Kohli23 May 2022 2:00 PM GMTOngoing long-term follow-up of Medicare patients who received paclitaxel-coated devices for the treatment of PAD continues to show no evidence of an...
Intravascular lithotripsy effective option for severely calcified peripheral lesions: Disrupt PAD III trial Dr. Kamal Kant Kohli20 May 2022 4:30 AM GMTATLANTA, GA: One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with a drug-coated balloon (DCB) to...
Home-based walking intervention improves walking distance in PAD: MOSAIC study Medical Dialogues Editorial Team16 April 2022 4:15 AM GMTA new study published in the Journal of American Medical Association suggests that a home-based, walking exercise habit modification intervention,...
PAD Causes Worse Outcome among patients with AMI and Cardiogenic shock MD Bureau2 April 2022 4:30 AM GMTCardiogenic shock (CS) complicates up to 10% of patients presenting with acute myocardial infarction (AMI), with one-third of those affected not...
Rivaroxaban & aspirin benefit PAD patients undergoing lower extremity revascularization: study Dr. Shravani Dali29 Oct 2021 4:15 AM GMTPatients with peripheral artery disease (PAD) undergoing lower extremity revascularization (LER) benefit from low-dose rivaroxaban and aspirin ...
Smoking status impacts outcomes of patients undergoing interventions for PAD, JAMA study dr. Abhimanyu Uppal8 Oct 2021 4:00 AM GMTSmoking is a key modifiable risk factor in the development and progression of peripheral artery disease, which often manifests as intermittent...
Intravascular lithotripsy better than PTA for peripheral artery calcification: JACC Medha Baranwal14 July 2021 3:30 AM GMTAustria: Vessel preparation with intravascular lithotripsy (IVL) prior to drug-coated balloon effectively facilitates endovascular treatment for...
Risk score may predict risk of major adverse limb events in diabetes patients: Study Medha Baranwal5 May 2021 3:17 AM GMTUSA: A risk score may identify patients with type 2 diabetes (T2D) at high risk for major adverse limb events (MALE) including those without a history...
The versatile drug Trimetazidine: Applications in angina and beyond Dr Tiny Nair26 April 2021 7:15 AM GMTTrimetazidine (TMZ), an anti-anginal agent with a unique pleiotropic profile of actions on the cardiac cells making it an effective anti-anginal...
High intensity exercise causing ischemic leg pain beneficial for PAD patients: JAMA Medha Baranwal7 April 2021 1:52 PM GMTUSA: The use of low-intensity walking exercise is significantly less effective than high-intensity home-based exercise in patients with peripheral...
Paclitaxel-coated devices not linked to death risk in PAD patients: NEJM Medha Baranwal6 Feb 2021 6:15 AM GMTSweden: The use of paclitaxel-coated devices versus uncoated endovascular devices is not associated with a significant increase in mortality risk,...
Rivaroxaban and Aspirin combo reduces vascular risk in Lower Extremity PAD: JAMA Dr. Nandita Mohan20 Jan 2021 12:30 PM GMTResearchers have recently observed that treatment with rivaroxaban and aspirin in combination compared with aspirin alone led to a large absolute...
